302 related articles for article (PubMed ID: 9169181)
21. Decline of Seroprevalence and Incidence of Congenital Toxoplasmosis Despite Changing Prevention Policy-Three Decades of Cord-blood Screening in North-western Switzerland.
Rudin C; Hirsch HH; Spaelti R; Schaedelin S; Klimkait T
Pediatr Infect Dis J; 2018 Nov; 37(11):1087-1092. PubMed ID: 29561516
[TBL] [Abstract][Full Text] [Related]
22. Late diagnosis of congenital toxoplasmosis based on serological follow-up: A case report.
Dard C; Chemla C; Fricker-Hidalgo H; Brenier-Pinchart MP; Baret M; Mzabi A; Villena I; Pelloux H
Parasitol Int; 2017 Apr; 66(2):186-189. PubMed ID: 27956093
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the usefulness of serological examinations in the prophylaxis of congenital toxoplasmosis in the materials of CM UJ Parasitology Department].
Dymon M; Kempińska A
Wiad Parazytol; 2001; 47 Suppl 1():59-64. PubMed ID: 16897953
[TBL] [Abstract][Full Text] [Related]
24. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy.
Rodrigues IM; Costa TL; Avelar JB; Amaral WN; Castro AM; Avelino MM
BMC Infect Dis; 2014 Jun; 14():349. PubMed ID: 24961630
[TBL] [Abstract][Full Text] [Related]
25. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.
Koskiniemi M; Lappalainen M; Koskela P; Hedman K; Ammälä P; Hiilesmaa V; Teramo K
Scand J Infect Dis Suppl; 1992; 84():70-4. PubMed ID: 1290079
[TBL] [Abstract][Full Text] [Related]
26. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.
Stepick-Biek P; Thulliez P; Araujo FG; Remington JS
J Infect Dis; 1990 Jul; 162(1):270-3. PubMed ID: 2192008
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and methods. The mother: evaluation of risks and data collection. Serology].
Bessières MH
Arch Pediatr; 2003 Feb; 10 Suppl 1():30-2. PubMed ID: 12802966
[No Abstract] [Full Text] [Related]
28. Toxoplasma gondii infection during pregnancy: a ten-year observation in the province of Trento, Italy.
Piffer S; Lauriola AL; Pradal U; Collini L; Dell'Anna L; Pavanello L
Infez Med; 2020 Nov; 28(4):603-610. PubMed ID: 33257637
[TBL] [Abstract][Full Text] [Related]
29. Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis.
Robert-Gangneux F; Commerce V; Tourte-Schaefer C; Dupouy-Camet J
Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):648-54. PubMed ID: 10534187
[TBL] [Abstract][Full Text] [Related]
30. Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria.
Berredjem H; Aouras H; Benlaifa M; Becheker I; Djebar MR
Afr Health Sci; 2017 Sep; 17(3):647-656. PubMed ID: 29085392
[TBL] [Abstract][Full Text] [Related]
31. Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia.
Gallego-Marín C; Henao AC; Gómez-Marín JE
J Trop Pediatr; 2006 Apr; 52(2):107-12. PubMed ID: 16014760
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.
Bessières MH; Berrebi A; Cassaing S; Fillaux J; Cambus JP; Berry A; Assouline C; Ayoubi JM; Magnaval JF
Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):389-92. PubMed ID: 19430670
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the postnatal treatment efficacy in congenital toxoplasmosis identified by the newborn screening programme].
Paul M; Jaworska A; Twardosz-Pawlik H; Szczapa J; Stefaniak J
Wiad Parazytol; 2001; 47 Suppl 1():107-12. PubMed ID: 16897960
[TBL] [Abstract][Full Text] [Related]
34. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of complications during pregnancy in women with serological features of acute toxoplasmosis or acute parvovirosis].
Marcinek P; Nowakowska D; Szaflik K; Spiewak E; Małafiej E; Wilczyński J
Ginekol Pol; 2008 Mar; 79(3):186-91. PubMed ID: 18592853
[TBL] [Abstract][Full Text] [Related]
36. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982-1999.
Signorell LM; Seitz D; Merkel S; Berger R; Rudin C
Pediatr Infect Dis J; 2006 Feb; 25(2):123-8. PubMed ID: 16462288
[TBL] [Abstract][Full Text] [Related]
37. [Prevention of congenital toxoplasmosis in a Buenos Aires hospital].
Carral L; Kaufer F; Olejnik P; Freuler C; Durlach R
Medicina (B Aires); 2013; 73(3):238-42. PubMed ID: 23732199
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis.
Sensini A
Clin Microbiol Infect; 2006 Jun; 12(6):504-12. PubMed ID: 16700697
[TBL] [Abstract][Full Text] [Related]
39. [Multicenter study on the prevention of congenital toxoplasmosis in Buenos Aires].
Carral L; Kaufer F; Durlach R; Freuler C; Olejnik P; Nadal M; Corazza R; Pari M; García L; Córdoba S; Rodriguez M; Ceriotto M; García G
Medicina (B Aires); 2008; 68(6):417-22. PubMed ID: 19147421
[TBL] [Abstract][Full Text] [Related]
40. Congenital toxoplasmosis: is screening desirable?
Foulon W
Scand J Infect Dis Suppl; 1992; 84():11-7. PubMed ID: 1290068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
